- Home
- ONEG vs INO Comparison
ONEG vs INO Comparison
Compare ONEG & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | INO |
|---|---|---|
| Founded | 2021 | 1979 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.2M | 136.6M |
| IPO Year | 2024 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ONEG | INO |
|---|---|---|
| Price | $1.21 | $2.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 564.2K | ★ 1.2M |
| Earning Date | 08-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $53,205,000.00 | $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21,219.94 |
| P/E Ratio | $15.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $1.30 |
| 52 Week High | $13.50 | $4.44 |
Technical Indicators
Market Signals| Indicator | ONEG | INO |
|---|---|---|
| Relative Strength Index (RSI) | 17.35 | 51.22 |
| Support Level | $1.07 | $1.86 |
| Resistance Level | $1.95 | $2.10 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 12.98 | 89.74 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.